Influence of TP53 Mutation on Survival of Diffuse Large B-Cell Lymphoma in the CAR T-Cell Era

SIMPLE SUMMARY: The genetic landscape of diffuse large B-cell lymphoma (DLBCL) is heterogenous. So far, detailed studies about TP53 mutations in DLBCL treated with anti-CD19 chimeric antigen receptor T-cell (CAR T cells) therapy are still missing. Chemotherapy resistance is one of the challenges in...

Descripción completa

Detalles Bibliográficos
Autores principales: Porpaczy, Edit, Wohlfarth, Philipp, Königsbrügge, Oliver, Rabitsch, Werner, Skrabs, Cathrin, Staber, Philipp, Worel, Nina, Müllauer, Leonhard, Simonitsch-Klupp, Ingrid, Kornauth, Christoph, Rohrbeck, Johannes, Jaeger, Ulrich, Schiefer, Ana-Iris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616128/
https://www.ncbi.nlm.nih.gov/pubmed/34830747
http://dx.doi.org/10.3390/cancers13225592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616128/
https://www.ncbi.nlm.nih.gov/pubmed/34830747
http://dx.doi.org/10.3390/cancers13225592

Ejemplares similares